• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向氯胺酮与心理治疗的协同作用。

Toward Synergies of Ketamine and Psychotherapy.

作者信息

Mathai David S, Mora Victoria, Garcia-Romeu Albert

机构信息

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

School of Health Professions, Baylor College of Medicine, Houston, TX, United States.

出版信息

Front Psychol. 2022 Mar 25;13:868103. doi: 10.3389/fpsyg.2022.868103. eCollection 2022.

DOI:10.3389/fpsyg.2022.868103
PMID:35401323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8992793/
Abstract

Ketamine is a dissociative drug that has been used medically since the 1970s primarily as an anesthetic agent but also for various psychiatric applications. Anecdotal reports and clinical research suggest substantial potential for ketamine as a treatment in conjunction with psychological interventions. Here, we review historical and modern approaches to the use of ketamine with psychotherapy, discuss the clinical relevance of ketamine's acute psychoactive effects, propose a unique model for using esketamine (one isomeric form of ketamine) with Acceptance and Commitment Therapy (ACT), and suggest considerations for moving medication-assisted psychotherapy forward as a field.

摘要

氯胺酮是一种分离性药物,自20世纪70年代以来一直在医学上使用,主要用作麻醉剂,但也用于各种精神科应用。轶事报道和临床研究表明,氯胺酮与心理干预相结合作为一种治疗方法具有巨大潜力。在此,我们回顾了氯胺酮与心理治疗结合使用的历史和现代方法,讨论了氯胺酮急性精神活性作用的临床相关性,提出了一种将艾司氯胺酮(氯胺酮的一种异构体形式)与接纳与承诺疗法(ACT)结合使用的独特模型,并提出了推动药物辅助心理治疗作为一个领域向前发展的考虑因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3556/8992793/856ba17eadd7/fpsyg-13-868103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3556/8992793/e0a4648e5142/fpsyg-13-868103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3556/8992793/856ba17eadd7/fpsyg-13-868103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3556/8992793/e0a4648e5142/fpsyg-13-868103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3556/8992793/856ba17eadd7/fpsyg-13-868103-g002.jpg

相似文献

1
Toward Synergies of Ketamine and Psychotherapy.迈向氯胺酮与心理治疗的协同作用。
Front Psychol. 2022 Mar 25;13:868103. doi: 10.3389/fpsyg.2022.868103. eCollection 2022.
2
A unified model of ketamine's dissociative and psychedelic properties.氯胺酮致分离性和致幻性的统一模型。
J Psychopharmacol. 2023 Jan;37(1):14-32. doi: 10.1177/02698811221140011. Epub 2022 Dec 17.
3
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach.氯胺酮辅助心理治疗、迷幻疗法以及主观性的不可撼动的价值——一种新的、不断发展的方法。
Front Psychiatry. 2024 Feb 1;15:1209419. doi: 10.3389/fpsyt.2024.1209419. eCollection 2024.
4
Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.氯胺酮治疗精神健康:急性精神活性作用与结果有关吗?系统综述。
Behav Brain Res. 2020 Aug 17;392:112629. doi: 10.1016/j.bbr.2020.112629. Epub 2020 May 30.
5
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.氯胺酮辅助心理治疗(KAP):在三家大型机构中,氯胺酮联合心理治疗的患者特征、临床数据和结局。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):189-198. doi: 10.1080/02791072.2019.1587556. Epub 2019 Mar 27.
6
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.蒙特利尔模型:一种针对氯胺酮治疗重度难治性抑郁症的综合生物医学-迷幻剂方法。
Front Psychiatry. 2023 Sep 19;14:1268832. doi: 10.3389/fpsyt.2023.1268832. eCollection 2023.
7
Mechanisms of ketamine action as an antidepressant.氯胺酮作为抗抑郁药的作用机制。
Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13.
8
Toward specific ways to combine ketamine and psychotherapy in treating depression.探讨将氯胺酮与心理疗法相结合治疗抑郁症的具体方法。
CNS Spectr. 2020 Jun;25(3):445-447. doi: 10.1017/S1092852919001007. Epub 2019 Jun 19.
9
Ketamine administration in depressive disorders: a systematic review and meta-analysis.氯胺酮在抑郁症治疗中的应用:一项系统综述和荟萃分析。
Psychopharmacology (Berl). 2014 Sep;231(18):3663-76. doi: 10.1007/s00213-014-3664-5. Epub 2014 Jul 20.
10
Ketamine Tolerance in Sprague-Dawley Rats after Chronic Administration of Ketamine, Morphine, or Cocaine.氯胺酮、吗啡或可卡因慢性给药后Sprague-Dawley大鼠的氯胺酮耐受性
Comp Med. 2019 Feb 1;69(1):29-34. doi: 10.30802/AALAS-CM-18-000053. Epub 2019 Jan 29.

引用本文的文献

1
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks.氯胺酮辅助康复(KARE):一项针对有甲基苯丙胺使用障碍和感染艾滋病毒风险的公共保险患者的氯胺酮辅助心理治疗开放标签试点试验方案。
BMJ Open. 2025 Aug 24;15(8):e100775. doi: 10.1136/bmjopen-2025-100775.
2
Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.用裸盖菇素进行迷幻治疗:应对医疗事故风险及医生的担忧。
J Law Med Ethics. 2025 Jul 31;53(2):1-9. doi: 10.1017/jme.2025.10109.
3
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

本文引用的文献

1
Ketamine Augmentation of Exposure Response Prevention Therapy for Obsessive-compulsive Disorder.氯胺酮增强暴露反应预防疗法治疗强迫症
Innov Clin Neurosci. 2021 Oct-Dec;18(10-12):9-11.
2
A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression.一项基于队列的病例报告:氯胺酮辅助治疗嵌入创伤后应激障碍和抑郁症医疗服务提供者实践社区框架的影响。
Front Psychiatry. 2022 Jan 12;12:803279. doi: 10.3389/fpsyt.2021.803279. eCollection 2021.
3
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review.
难治性抑郁症患者使用鼻内艾氯胺酮的体验:一项意大利多中心研究(REAL-ESKperience)的见解
J Pers Med. 2025 Apr 21;15(4):161. doi: 10.3390/jpm15040161.
4
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data.家庭环境下、远程医疗支持的氯胺酮治疗抑郁症:真实世界数据的纵向、机器学习和症状网络分析结果。
J Affect Disord. 2024 Sep 15;361:198-208. doi: 10.1016/j.jad.2024.05.131. Epub 2024 May 27.
5
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach.氯胺酮辅助心理治疗、迷幻疗法以及主观性的不可撼动的价值——一种新的、不断发展的方法。
Front Psychiatry. 2024 Feb 1;15:1209419. doi: 10.3389/fpsyt.2024.1209419. eCollection 2024.
6
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.创伤后应激障碍治疗的迷幻未来。
Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147.
7
Treating Treatment-resistant Depression with Esketamine Nasal Spray When All Therapeutic Options Have Been Exhausted: Clinical Experience from a Spanish Cohort of Expanded Use.当所有治疗方案均已用尽时,使用艾氯胺酮鼻喷雾剂治疗难治性抑郁症:来自西班牙扩大使用队列的临床经验
Clin Psychopharmacol Neurosci. 2024 Feb 29;22(1):159-168. doi: 10.9758/cpn.23.1097. Epub 2023 Sep 6.
8
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.两种致幻剂右美沙芬和裸盖菇素的双盲比较:健康志愿者中与体验相关且持久的心理效应
Psychedelic Med (New Rochelle). 2023 Dec 1;1(4):241-252. doi: 10.1089/psymed.2023.0035. Epub 2023 Dec 13.
9
Ketamine for Major Depressive Disorder.氯胺酮治疗重度抑郁症。
Curr Top Behav Neurosci. 2024;66:131-147. doi: 10.1007/7854_2023_453.
10
Suicide prevention and ketamine: insights from computational modeling.自杀预防与氯胺酮:计算建模的见解
Front Psychiatry. 2023 Jun 29;14:1214018. doi: 10.3389/fpsyt.2023.1214018. eCollection 2023.
氯胺酮用于治疗精神健康和物质使用障碍:全面系统评价
BJPsych Open. 2021 Dec 23;8(1):e19. doi: 10.1192/bjo.2021.1061.
4
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.(标题):难治性抑郁症患者使用氯胺酮鼻喷雾剂的解离与抗抑郁作用之间的关系。
Int J Neuropsychopharmacol. 2022 Apr 19;25(4):269-279. doi: 10.1093/ijnp/pyab084.
5
Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.辅助氯胺酮联合基于预防复发的心理治疗用于酒精使用障碍的治疗
Am J Psychiatry. 2022 Feb;179(2):152-162. doi: 10.1176/appi.ajp.2021.21030277. Epub 2022 Jan 11.
6
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression.氯胺酮治疗的综合方法可能会增强疗效的多个维度:改善难治性抑郁症的治疗效果。
Front Psychiatry. 2021 Nov 24;12:710338. doi: 10.3389/fpsyt.2021.710338. eCollection 2021.
7
[Ketamine Augmented Psychotherapy (KAP) in mood disorder: User guide].[氯胺酮强化心理治疗(KAP)在情绪障碍中的应用:用户指南]
Encephale. 2022 Jun;48(3):304-312. doi: 10.1016/j.encep.2021.08.011. Epub 2021 Dec 4.
8
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy.病例报告:极端且持久的神经性贪食症经反复氯胺酮辅助心理治疗后意外缓解
Front Psychiatry. 2021 Nov 17;12:764112. doi: 10.3389/fpsyt.2021.764112. eCollection 2021.
9
Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and Suicidality.父母对氯胺酮在青少年心境障碍和自杀中的使用的态度。
J Child Adolesc Psychopharmacol. 2021 Oct;31(8):553-561. doi: 10.1089/cap.2021.0078.
10
Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy.关键期可塑性作为迷幻辅助心理治疗的框架
Front Neurosci. 2021 Sep 20;15:710004. doi: 10.3389/fnins.2021.710004. eCollection 2021.